1. 365ODurability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer. (24th November 2019) Authors: Hyman, D; Tan, D S W; van Tilburg, C; Albert, C; Geoerger, B; Farago, A; Laetsch, T; Kummar, S; Doz, F; Lassen, U; Dubois, S; McDermott, R; Mascarenhas, L; Berlin, J; Rudzinski, E; Nanda, S; Childs, B; Drilon, A; Hong, D S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. (2nd July 2019) Authors: Reni, M; Riess, H; O'Reilly, E; Santoro, A; Park, J; Bekaii-Saab, T; Tempero, M; Shan, Y; Macarulla, T; Cutsem, E Van; Noel, M; Berlin, J; Biankin, A; Dhani, N; Frassineti, G; Goldstein, D; Romano, A; Bruchec, Y Le; Philip, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-001Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. (2nd July 2019) Authors: Reni, M; Winter, J; Tortora, G; Pelzer, U; Riess, H; Chang, H; O'Reilly, E; Oh, D; Diaz, I Alés; Milella, M; Bendell, J; Garlipp, B; Tempero, M; Macarulla, T; Van Cutsem, E; Berlin, J; Goldstein, D; Lu, B; Jeanes, J; Philip, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗